Clinical Trial Update: Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and effectiveness of a three-drug regimen (emtricitabine, efavirenz, and didanosine) in HIV-infected children with limited pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Didanosine (didanosine)
• EFAVIRENZ (efavirenz)
• Emtricitabine (Emtricitabine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-17